Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Bluejay Diagnostics Inc. Common Stock
BJDX | US
1.78
USD-0.03
-1.66%
BJDX | US
Loading StockChartView...
About Bluejay Diagnostics Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
10/04/2026
Close
1.78
Open
1.83
High
1.95
Low
1.77
Bluejay Diagnostics Inc. a medical diagnostic company develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform a technology platform comprising Symphony analyzer that orchestrates blood processing biomarker isolation and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge which includes reagents and components. The company also offers ALLEREYE diagnostic test a point-of-care device for the diagnosis of allergic conjunctivitis. In addition it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton Massachusetts.
View LessBJDX | US
Risk
71.7
Sharpe
-0.66
Luna's Score
43/100
Recommendation
Sell
Luna says (BJDX | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
90.4%1 month
71.7%3 months
99.4%6 months
96.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.18
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
-0.10
Ent. to rev.
5.67
PEG
-
Other Fundamentals
EBITDA
-8.74M
MarketCap
29.46M
MarketCap(USD)
29.46M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-125.25
Short ratio
0.04
Short perc.
0.24
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.46
Range1M
0.46
Range3M
3.22
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.82
Price X volume
65.43K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.10 | 46.09 | Cheaper |
| Ent. to Revenue | 5.67 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.18 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 99.37 | 64.12 | Riskier |
| Debt to Equity | 0.05 | -145.53 | Expensive |
| Debt to Assets | 0.04 | 0.35 | Cheaper |
| Market Cap | 29.46M | 9.70B | Emerging |
